Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases

被引：7
作者：
Brandsma, D
Taphoorn, MJB
de Jager, W
Bonfrer, H
Algra, A
Reijneveld, JC
Boogerd, W
Korse, T
Verbeek, MM
Rijkers, GT
Voest, EE
机构：
[1] Univ Utrecht, Med Ctr, Dept Neurol, Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Lab Med Oncol, Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Med Oncol, Utrecht, Netherlands
[4] Univ Utrecht, Med Ctr, Dept Clin Epidemiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[5] Med Ctr Haaglanden, Dept Neurol, The Hague, Netherlands
[6] Univ Utrecht, Ctr Med, Wilhelminas Childrens Hosp, Utrecht, Netherlands
[7] Univ Utrecht, Ctr Med, Dept Pediat, Utrecht, Netherlands
[8] IACOPO Inst Translat Med, Utrecht, Netherlands
[9] Antoni Van Leeuwenhoek Hosp, Dept Clin Chem, Amsterdam, Netherlands
[10] Antoni Van Leeuwenhoek Hosp, Dept Neurol, Amsterdam, Netherlands
[11] Univ Nijmegen, Ctr Med, Dept Neurol, Nijmegen, Netherlands
来源：
NEUROLOGY | 2006年 / 66卷 / 02期
关键词：
D O I：
10.1212/01.wnl.0000194239.74384.57
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Median survival of patients with leptomeningeal metastases (LM) is 4 to 6 months, with a few long-term survivors. Current prognostic factors for survival have limited value. The authors measured the CSF levels of nine inflammatory proteins in 57 patients with LM and determined their prognostic value. High interleukin (IL)-8 CSF levels predicted short-term survival independently. The data indicate that IL-8 CSF levels may serve as a prognosticator in patients with LM, but prospective validation is needed.
引用
收藏
页码：243 / 246
页数：4
相关论文
共 13 条
[1]   Human chemokines: An update [J].
Baggiolini, M ;
Dewald, B ;
Moser, B .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :675-705
[2]   Leptomeningeal carcinomatosis - Presenting features and prognostic factors [J].
Balm, M ;
Hammack, J .
ARCHIVES OF NEUROLOGY, 1996, 53 (07) :626-632
[3]  
BOOGERD W, 1991, CANCER, V67, P1685, DOI 10.1002/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO
[4]  
2-M
[5]   Vascular cell adhesion molecule-1 is a key adhesion molecule in melanoma cell adhesion to the leptomeninges [J].
Brandsma, D ;
Reijneveld, JC ;
Taphoorn, MJB ;
de Boer, HC ;
Gebbink, MFBG ;
Ulfman, LH ;
Zwaginga, JJ ;
Voest, EE .
LABORATORY INVESTIGATION, 2002, 82 (11) :1493-1502
[6]   Leptomeningeal metastases: A review of evaluation and treatment [J].
Chamberlain, MC .
JOURNAL OF NEURO-ONCOLOGY, 1998, 37 (03) :271-284
[7]   Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells [J].
de Jager, W ;
te Velthuis, H ;
Prakken, BJ ;
Kuis, W ;
Rijkers, GT .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (01) :133-139
[8]   Leptomeningeal metastases [J].
Demopoulos A. .
Current Neurology and Neuroscience Reports, 2004, 4 (3) :196-204
[9]  
JAYSON GC, 1994, CANCER, V74, P3135, DOI 10.1002/1097-0142(19941215)74:12<3135::AID-CNCR2820741212>3.0.CO
[10]  
2-8
12